Article

Ophthalmology Times Expert Insight Contest Entry Form

Ophthalmology Times Expert Insight Contest Entry Form

Related Videos
Related Content
Unlocking health mysteries
October 15th 2024

Unlocking health mysteries

Week in Review - October 5, 2024
October 13th 2024

Week in Review - October 5, 2024

First patient dosed at the Tokyo Medical Center by Belite Bio in Phase 2/3 DRAGON II clinical trial
Published: October 12th 2024 | Updated: October 11th 2024

First patient dosed at the Tokyo Medical Center by Belite Bio in Phase 2/3 DRAGON II clinical trial

EyePod: AI’s impact on managing ocular surface disease with Peter J. McDonnell, MD, and Laura M. Periman, MD
October 11th 2024

Innovation Series: AI’s impact on managing ocular surface disease with Peter J. McDonnell, MD, and Laura M. Periman, MD

Melt Pharmaceuticals doses final patient in phase 3 trial of MELT-300
October 11th 2024

Melt Pharmaceuticals doses final patient in phase 3 trial of MELT-300

Key lectures and awards at the AAO 2024 meeting
October 11th 2024

Key lectures and awards at the AAO 2024 meeting

© 2024 MJH Life Sciences

All rights reserved.